Skip to content

NEXIEN BIOPHARMA, INC.: filings

Every NEXIEN BIOPHARMA, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 42 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2025-05-14fiscal Q3 202521690001641172-25-010067
10-Q2025-02-14fiscal Q2 202521640001493152-25-006734
10-Q2024-11-18fiscal Q1 202521420001493152-24-046468
10-K2024-10-22fiscal FY 202421410001493152-24-041978
10-Q2024-05-15fiscal Q3 202421660001493152-24-019400
10-Q2024-02-20fiscal Q2 202420610001493152-24-007096
10-Q2023-11-14fiscal Q1 202420400001493152-23-041255
10-K2023-09-28fiscal FY 202321410001493152-23-034480
10-Q2023-05-17fiscal Q3 202317550001493152-23-017925
10-Q2023-02-08fiscal Q2 202316490001493152-23-003903
10-Q2022-11-09fiscal Q1 202315320001493152-22-031033
10-K2022-09-28fiscal FY 202218360001493152-22-026974
10-Q2022-05-12fiscal Q3 202216440001493152-22-012957
10-Q2022-02-08fiscal Q2 202214370001493152-22-003407
10-Q2021-11-22fiscal Q1 202215290001493152-21-029479
10-K2021-10-12fiscal FY 202115300001493152-21-025119
10-Q2021-05-05fiscal Q3 202116360001493152-21-010467
10-Q2021-02-11fiscal Q2 202117400001493152-21-003367
10-Q2020-11-10fiscal Q1 202117320001493152-20-020864
10-K2020-09-28fiscal FY 202020340001493152-20-018396
10-Q2020-05-14fiscal Q3 202016380001493152-20-008614
10-Q2020-02-12fiscal Q2 202016380001493152-20-002009
10-Q2019-11-12fiscal Q1 202015300001493152-19-016795
10-K2019-09-30fiscal FY 201919360001493152-19-014714
10-Q2019-05-14fiscal Q3 201919450001493152-19-006990
10-Q2019-02-14fiscal Q2 201919430001493152-19-001882
10-Q2018-11-14fiscal Q1 201919360001493152-18-015814
10-K2018-09-28fiscal FY 201819360001493152-18-013863
10-Q2018-05-15fiscal Q3 201818430001493152-18-006883
10-Q2018-02-14fiscal Q2 201818310001493152-18-002091
10-Q2017-11-03fiscal Q1 201813250001493152-17-012370
10-K2017-07-31fiscal FY 201715300001295345-17-000219
10-Q2017-05-04fiscal Q3 201715360001295345-17-000109
10-Q2017-02-06fiscal Q2 201714360001295345-17-000012
10-Q2016-10-19fiscal Q1 201714280001295345-16-000717
10-K2016-09-28fiscal FY 201614280001295345-16-000689
10-Q2016-04-13fiscal Q3 201617420001295345-16-000507
10-Q2016-02-04fiscal Q2 201614360001295345-16-000425
10-Q2015-10-14fiscal Q1 201614270001295345-15-000302
10-K2015-09-15fiscal FY 201516320001295345-15-000260
10-Q2015-05-06fiscal Q3 201516400001295345-15-000110
10-Q2015-02-13fiscal Q2 201516400001295345-15-000028

Inspect the source

Entity
NEXIEN BIOPHARMA, INC. / CIK 0001625288
Captured
2026-09-21T17:21:50.748Z
SEC response SHA-256
044a00232373cfad706e13d40a0fcc524943f52c3deb14bbc85e1072ff58fe5c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001625288.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))